Home › Triple-Negative Breast Cancer › New York › Buffalo
Triple-Negative Breast Cancer clinical trials in Buffalo, NY
7 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Buffalo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Intratumoral N17350 in Advanced Solid Tumors
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
RecruitingPhase 2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
- Roswell Park Cancer Institute, Buffalo
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
RecruitingPhase 2
- Roswell Park Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecruitingPhase 2
- Roswell Park Cancer Institute, Buffalo
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
RecruitingPhase 2
- Roswell Park Cancer Institute, Buffalo
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RecruitingPhase 1/2
- Roswell Park Cancer Institute, Buffalo
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Buffalo
- Non-Small Cell Lung Cancer19 studies
- Cancer (all types)19 studies
- Acute Myeloid Leukemia19 studies
- Lung Cancer16 studies
- Breast Cancer16 studies
- Ovarian Cancer13 studies
- Metastatic Cancer11 studies
- Prostate Cancer11 studies
- Melanoma10 studies
- Multiple Myeloma10 studies
- Obesity9 studies
- Burkitt Lymphoma8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.